High performance liquid chromatography using UV detection for the simultaneous quantification of the new non-nucleoside reverse transcriptase inhibitor etravirine (TMC-125), and 4 protease inhibitors in human plasma

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 8, 2010, Pages 1426-1429

  Hirano, Atsushi ^a,b   Takahashi, Masaaki ^a   Kinoshita, Eri ^a   Shibata, Masaaki ^a   Nomura, Toshiharu ^a   Yokomaku, Yoshiyuki ^a   Hamaguchi, Motohiro ^a   Sugiura, Wataru ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Etravirine; HPLC; Protease inhibitor; Therapeutic drug monitoring

Indexed keywords

ATAZANAVIR; DARUNAVIR; ETRAVIRINE; LAMIVUDINE; LOPINAVIR; RALTEGRAVIR; RITONAVIR;

ACCURACY; ADULT; ANALYTIC METHOD; CASE REPORT; CD4 LYMPHOCYTE COUNT; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; NOTE; QUANTITATIVE STUDY; ULTRAVIOLET RADIATION; VIRUS LOAD;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; PYRIDAZINES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE INHIBITORS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 77956098416     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1426     Document Type: Note

References (11)

1. Madruga J. V., Cahn P., Grinsztejn B., Haubrich R., Lalezari J., Mills A., Pialoux G., Wilkin T., Peeters M., Vingerhoets J., de Smedt G., Leopold L., Trefiglio R., Woodfall B., Lancet, 370, 29-38 (2007).
2. Lazzarin A., Campbell T., Clotet B., Johnson M., Katlama C., Moll A., Towner W., Trottier B., Peeters M., Vingerhoets J., de Smedt G., Baeten B., Beets G., Sinha R., Woodfall B., Lancet, 370, 39-48 (2007).
3. Katlama C., Haubrich R., Lalezari J., Lazzarin A., Madruga J. V., Molina J. M., Schechter M., Peeters M., Picchio G., Vingerhoets J., Woodfall B., De Smedt G., AIDS, 23, 2289-2300 (2009).
4. The Panel on Clinical Practices for Treatment of HIV Infection Convened by the Department of Health and Human Services (DHHS), Published at http://AIDSinfo.nih.gov, 1 December 2009.
5. Fayet A., Beguin A., Zanolari B., Cruchon S., Guignard N., Telenti A., Cavassini M., Gunthard H. F., Buclin T., Biollaz J., Rochat B., Decosterd L. A J. Chromatogr, B, Analyt. Technol. Biomed. Life Sci, 877, 1057-1069 (2009).
6. Quaranta S., Woloch C., Paccou A., Giocanti M., Solas C., Lacarelle B., Ther. Drug Monit., 31, 695-702 (2009).
7. Rezk N. L., White N. R., Jennings S. H., Kashuba A. D., Talanta, 79, 1372-1378 (2009).
8. D'Avolio A., Baietto L., Siccardi M., Sciandra M., Simiele M., Oddone V., Bonora S., Di Perri G., Ther. Drug Monit., 30, 662-669 (2008).
9. Takahashi M., Yoshida M., Oki T., Okumura N., Suzuki T., Kaneda T., Biol. Pharm. Bull., 28, 1286-1290 (2005).
10. Product Information, INTELENCE (etravirine tablet), Tibotec Therapeutics, Bridgewater, NJ, U.S.A.: http://www.intelence-info.com/intelence/
11. Andries K., Azijin H., Thielemans T., Ludovici D., Kukla M., Heeres J., Janssen P., De Corte B., Vingerhoets J., Pauwels R., de Bethune M. P., Antimicrob. Agents Chemother., 48, 4680-4686 (2004).